Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Weekly
Analytics
Project Updates and Milestones news
(page 5)
25 November 2025
Celtic Renewables Partners with Allen Associates for Grangemouth Biorefinery Design
A new biorefinery in Grangemouth will be ten times larger than the current plant, with a FEED study enhancing cost accuracy and project planning.
25 November 2025
Novo Nordisk Reports Phase 2 Success with Amycretin in Type 2 Diabetes
Amycretin shows significant HbA1c reduction and weight loss in type 2 diabetes patients, with a safe profile. Phase 3 trials planned for 2026.
24 November 2025
Novo Nordisk: Phase 3 Trials Show No Significant Impact on Alzheimer's Progression
Semaglutide showed no significant effect on Alzheimer's progression in phase 3 trials, despite improving biomarkers. Trials will not continue due to lack of efficacy.
21 November 2025
EEW Premnitz Launches Germany's First Waste-to-Energy Plant with Battery Storage
Battery storage at Premnitz enhances energy flexibility, stabilizes grid, and supports energy transition by storing surplus electricity and meeting demand peaks.
21 November 2025
Merck's KEYTRUDA and Padcev Approved by FDA for Bladder Cancer Treatment
FDA approves first PD-1 inhibitor plus ADC regimens for cisplatin-ineligible muscle-invasive bladder cancer, based on KEYNOTE-905 trial results showing significant EFS improvement.
21 November 2025
Orano's Uranium Enrichment Expansion: EIB Site Visit
EIB delegation visits Tricastin to review progress on the €1.7B Georges Besse 2 expansion, enhancing EU energy sovereignty with new enrichment modules operational by 2030.
News type
New Projects and Expansions
New Projects and Expansions
Project Updates and Milestones
Project Updates and Milestones
Mergers, Acquisitions, and Partnerships
Mergers, Acquisitions, and Partnerships
Innovation and Product Development
Innovation and Product Development
Operational Changes and Investments
Operational Changes and Investments
Sustainability and Environmental Initiatives
Sustainability and Environmental Initiatives
Financial Performance and Strategy
Financial Performance and Strategy
Executive Appointments and Governance Changes
Executive Appointments and Governance Changes
Regulatory and Compliance Updates
Regulatory and Compliance Updates
Workforce and Corporate Social Responsibility (CSR)
Workforce and Corporate Social Responsibility (CSR)
Crisis and Risk Management
Crisis and Risk Management
The right choices in the European chemical industry
Save time with
chemXplore Analytics
Learn more
20 November 2025
Tecnimont Launches Tengiz Gas Separation Project and Local Content Forum in Kazakhstan
The Tengiz Gas Separation Complex aims to recover 98% ethane, supporting local industry and community development through a forum with 400 Kazakh companies.
20 November 2025
Tecnimont (Maire) Launches Tengiz Gas Separation Complex and Hosts Local Content Forum in Kazakhstan
The Tengiz Gas Separation Complex project begins, aiming to boost Kazakhstan's petrochemical sector and engage local businesses through a dedicated forum.
20 November 2025
Nobian's Salt Mining in Heiligerlee Extended to 2035
Dutch ministry approves salt mining extension in Heiligerlee until 2035, ensuring supply for chemical production. Additional studies on cavern closure and soil subsidence required.
20 November 2025
Boehringer Ingelheim's Avian Flu Vaccines Receive EU CVMP Approval
EU CVMP endorses VAXXITEK® and VAXXINACT® vaccines for H5 avian flu, enhancing outbreak preparedness and supporting safe trade with DIVA technology.
20 November 2025
Sinopec Projects Chosen for National Intelligent Factory Recognition
Three projects were recognized as exemplary intelligent factories, highlighting advancements in AI, system integration, and digital transformation in manufacturing.
20 November 2025
ORLEN Group Reports Record Q3 2025 Profit and Investment
ORLEN's Q3 2025 saw high investment in energy security, record dividends, and growth in renewable capacity, with strong performance across all segments despite challenging conditions.
19 November 2025
Terumo Aortic Launches Fenestrated TREO® IDE Study in US
The study evaluates endovascular repair of aortic aneurysms using the Fenestrated TREO® System, enrolling 210 patients across 45 US sites, with a 5-year follow-up.
19 November 2025
Sinopec Shanxi Enterprises Highlight 14th Five-Year Plan Achievements
Sinopec's Shanxi units enhanced energy supply, green initiatives, and local collaboration, achieving significant growth in natural gas, geothermal heating, and carbon reduction.
19 November 2025
TotalEnergies Boosts Stake in Nigeria's OPL257
TotalEnergies acquires 50% of OPL257 from Conoil, increasing its stake to 90%. Conoil gains 40% in OML136. The deal supports Egina South field development. Completion awaits approvals.
19 November 2025
Merck's KEYTRUDA® Subcutaneous Form Approved by European Commission
KEYTRUDA SC, a subcutaneous immune checkpoint inhibitor, is approved in Europe for faster administration across all adult indications.
19 November 2025
Merck Reports Positive Phase 3 Trial Results for HIV-1 Treatment DOR/ISL
DOR/ISL shows non-inferiority to BIC/FTC/TAF in HIV-1 treatment-naïve adults, meeting efficacy and safety goals. Detailed findings to be presented at a future scientific congress.
18 November 2025
Borouge Supplies Polyolefin for ROX Motor's ADAMAS SUV
Borouge's materials will be used in 17 components of the ADAMAS SUV, enhancing sustainability and supporting UAE's Operation 300 billion strategy for local manufacturing growth.
18 November 2025
Vega Ploieşti Refinery: 120 Years of Operation
Vega, a key player in Romania's industry, evolved from crude oil processing to niche production, supplying bitumen, hexane, and solvents, adapting to market changes over 120 years.
18 November 2025
UPM and GeBE Achieve Milestone in Adhesive Material Performance
OptiCut RL54 enables two million cuts without blade cleaning, reducing maintenance and extending equipment lifespan in GeBE's linerless printers.
18 November 2025
Genmab's EPKINLY Combination Approved by FDA for Relapsed Follicular Lymphoma
EPKINLY + R² shows superior progression-free survival and response rates in Phase 3 trial for relapsed follicular lymphoma, with a consistent safety profile.
18 November 2025
Merck's WINREVAIR Achieves Primary Endpoint in Phase 2 Study for Pulmonary Hypertension
WINREVAIR reduced pulmonary vascular resistance in Phase 2 CADENCE study, supporting Phase 3 development for treating pulmonary hypertension due to heart failure with preserved ejection fraction.
18 November 2025
ORLEN's Baltic East Wind Farm Secures Environmental Approval
Baltic East project advances with environmental approval, enabling participation in Poland's first offshore wind auction, aiming for 1 GW capacity and strong local supplier involvement.
18 November 2025
Equinor Completes Investigation of Hammerfest LNG Exposure Incidents
Venting from MEG tanks caused exposure incidents at Hammerfest LNG. Insufficient risk assessment and follow-up were identified. Measures now in place to manage risk effectively.
18 November 2025
Roche's Giredestrant Shows Superior Survival in Early Breast Cancer
Giredestrant shows significant benefit in early-stage ER-positive, HER2-negative breast cancer, with positive trends in overall survival and a favorable safety profile.
17 November 2025
Verso Energy Awards FEED Contract to Rely for DEZiR Project
DEZiR eSAF project in France advances to FEED stage, aiming to decarbonize aviation with scalable Methanol-to-Jet production, supported by EU and France 2030 programs.
17 November 2025
Carbon Centric Achieves FSSC 22000 for Food Grade CO₂ Production
Rakkestad plant certified for food grade CO₂ with 99.99% purity, supporting future storage and e-fuel applications.
17 November 2025
TechnipFMC Secures iEPCI Contract for Eni's Maha Project in Indonesia
TechnipFMC to deploy Subsea 2.0® technology for Eni's deepwater Maha project, enhancing timeline certainty and leveraging past regional project experience.
17 November 2025
Toray's Saudi Facility Pioneers Integrated RO Membrane Production
Toray's new Saudi facility boosts desalination with integrated RO membrane production, supporting sustainable water solutions in the Middle East and North Africa.
17 November 2025
Johnson & Johnson's TREMFYA® Proven to Inhibit Joint Damage in Psoriatic Arthritis
TREMFYA® reduces symptoms and inhibits joint damage in psoriatic arthritis, with sustained effects and improved ACR50 response rates through 48 weeks, maintaining a consistent safety profile.
← Previous
Next →
